Drosophila Clc-c model of Dent disease and human ClC-5 mutations
Drosophila Clc-c model of Dent disease and human ClC-5 mutations
批准号:
10314433
负责人:
Carmen Reynolds
金额:
$6.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-29 至 2022-07-28
关键词:
AffectAgeAmino AcidsAnimal ModelAnionsBiologicalBiological ModelsBiophysicsCLC GeneCalciumCalcium OxalateCell Culture TechniquesCellular biologyCharacteristicsChloridesClinicalComplicationCrystal FormationCrystallizationCultured CellsDataDent DiseaseDependenceDevelopmentDialysis procedureDietDrosophila genusDrosophila melanogasterElectrophysiology (science)EndosomesEvaluationExcretory functionExhibitsExperimental ModelsFamilyFellowshipGeneticHealthHumanIn VitroIndividualIon TransportIonsKidneyKidney CalculiKidney FailureKidney TransplantationLocationMalabsorption SyndromesMalpighian TubulesMembrane Transport ProteinsMethodsMicrodissectionModelingMolecular WeightMonitorMutateMutationNephrocalcinosisNephronsPartner in relationshipPathogenicityPatientsPhenotypePhysiologyPropertyProteinsPublishingRenal tubule structureResearchRiskRoleSeveritiesSiteStudy modelsTestingTimeTissuesTrainingTransgenesTransgenic OrganismsTranslatingTubular formationVariantabsorptionantibody detectionbasebiophysical propertiescalcificationcareerdietaryexperimental studyfluorophoreflygenetic manipulationhypercalciuriain vivoin vivo evaluationknock-downmouse modelrenal calciumrenal epitheliumsensorurinaryvoltagevoltage clamp
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Mutations in the human 2Cl-/H+ membrane transporter, CLC-5, cause Dent disease, which is clinically
characterized by increased renal excretion of low molecular weight protein (LMWP), Ca2+ (hypercalciuria),
increased risk for kidney stones, calcification of the kidney tissue, and progressive renal failure by age 20-40.
The involvement of CLC-5 in LMWP has been postulated and tested, but its role in renal Ca2+ mishandling is
unknown due to the lack of an appropriate experimental model. I hypothesize that Drosophila melanogaster
(i.e., fruit fly) may be an excellent model organism to study this Cl- transporter for the following justifications: (1)
flies natively express a Cl- transporter (Clc-c) that is >60% identical to human CLC-5, (2) calcium crystal
formation in fly renal epithelia recapitulate mammalian/human kidney stones and are easily induced for
quantification in real time, (3) genetic manipulations in flies are easy, quick (i.e., one mating and progeny in 7-
10 days), and tissue-specific to allow for evaluation of in vivo function with mutated native or transgenic
proteins, and (4) fly lines expressing genetically encoded fluorescent ion-sensors (H+, Cl-, Ca2+) allow
assessment of in vivo ion transport. Our preliminary evaluations and experiments have identified that all known
CLC-5 Dent mutations are conserved in the Clc-c sequence and that Clc-c and CLC-5 have similar voltage-
dependent and ion-transport characteristics. In addition, knockdown of Clc-c in renal tubules increases calcium
oxalate crystal formation compared to wildtype tubules, similar to increased kidney stone formation in Dent
disease. In this proposal, I hypothesize that Drosophila Clc-c shares additional biophysical and phenotypical
properties with those of CLC-5 and is similarly affected by mutations of conserved amino acid residues. My first
aim proposes to compare the biophysical features of Clc-c to those of CLC-5 by using voltage clamp
assessments, including determining the effect of homologous Dent mutations on the activity of the respective
transporter. Second, I intend to evaluate Drosophila Clc-c in vivo. The second aim will be tested by (1)
examining the cellular and subcellular localizations of Clc-c by antibody detection and of ions by expressing
genetically-encoded ion sensors for Cl- and H+, and (2) comparing crystal formation and ion secretion in
Malpighian tubules among WT flies and Clc-c knock-down flies by both in vivo and ex vivo methods. These
results will determine if Clc-c is an efficient and effective model for studying the biological role in renal calcium
and protein absorption of this Cl- transporter and Dent disease. The proposed fellowship training plan is
focused on developing diverse technical perspectives and embellishing professional development activities
that translate to a successful career in research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: